Skip to main content
Figure 4 | BMC Nephrology

Figure 4

From: Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland

Figure 4

Hb and EPO dose, according to co-morbidities and/or primary renal diagnosis. The mean ± SD of Hb and EPO doses as calculated in figure 3 are shown according to comorbidities or the primary renal diagnosis. Diabetes: n = 96; pyelonephritis/interstitial nephritis (PN/IN): n = 61; glomerulonephritis (GN): n = 78; coronary artery disease (CAD): n = 88; congestive heart failure (HF): n = 55; cancer (ca): n = 14 (prostate ca (n = 2), ear-nose-throat ca (n = 1), stomach ca (n = 1), others ca non specified (n = 10); chronic obstructive pulmonary disease (COPD): n = 5. 1p = 0.004; 2p = 0.003; 3p = 0.008.

Back to article page